PL2442811T3 - Teobromina w terapii kaszlu - Google Patents

Teobromina w terapii kaszlu

Info

Publication number
PL2442811T3
PL2442811T3 PL10725493T PL10725493T PL2442811T3 PL 2442811 T3 PL2442811 T3 PL 2442811T3 PL 10725493 T PL10725493 T PL 10725493T PL 10725493 T PL10725493 T PL 10725493T PL 2442811 T3 PL2442811 T3 PL 2442811T3
Authority
PL
Poland
Prior art keywords
theobromine
cough
treatment
Prior art date
Application number
PL10725493T
Other languages
English (en)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Infirst Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infirst Healthcare Ltd filed Critical Infirst Healthcare Ltd
Publication of PL2442811T3 publication Critical patent/PL2442811T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL10725493T 2009-06-16 2010-06-15 Teobromina w terapii kaszlu PL2442811T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0910375.5A GB0910375D0 (en) 2009-06-16 2009-06-16 Drug composition and its use in therapy
PCT/GB2010/050997 WO2010146394A1 (en) 2009-06-16 2010-06-15 Theobromine for the treatment of cough
EP10725493.0A EP2442811B1 (en) 2009-06-16 2010-06-15 Theobromine for the treatment of cough

Publications (1)

Publication Number Publication Date
PL2442811T3 true PL2442811T3 (pl) 2015-06-30

Family

ID=40940905

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10725493T PL2442811T3 (pl) 2009-06-16 2010-06-15 Teobromina w terapii kaszlu

Country Status (7)

Country Link
US (1) US8703158B2 (pl)
EP (1) EP2442811B1 (pl)
JP (1) JP5501451B2 (pl)
ES (1) ES2526560T3 (pl)
GB (1) GB0910375D0 (pl)
PL (1) PL2442811T3 (pl)
WO (1) WO2010146394A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
GB201014391D0 (en) * 2010-08-27 2010-10-13 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI81258C (fi) * 1982-02-01 1990-10-10 Sandoz Ag Foerfarande foer framstaellning av en farmaceutisk komposition foer nasal administration.
CY1490A (en) * 1982-02-01 1990-02-16 Sandoz Ltd Improvements in or relating to nasal pharmaceutical compositions
ATE108064T1 (de) 1987-10-08 1994-07-15 Andor Bilas Stoffgemisch zur stabilisierung der stoffwechsel- lage.
CN1130354A (zh) 1993-09-07 1996-09-04 普罗克特和廿保尔公司 含有丙酸类非甾体消炎药氨基酸盐和减充血药、祛痰药、抗组胺药和镇咳药中至少一种的组合物
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
DE4420708A1 (de) * 1994-06-14 1995-12-21 Euro Celtique Sa Entzündungshemmende Zusammensetzung zur Inhalation
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
AU4699299A (en) 1998-06-26 2000-01-17 Nutracorp Scientific, Inc. Promoting nitric oxide and cyclic gmp activity
HUP9802716A3 (en) 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
JP2002193839A (ja) 2000-12-27 2002-07-10 Meiji Seika Kaisha Ltd ココア製剤
JP2003128549A (ja) 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
JP2003055258A (ja) 2001-08-16 2003-02-26 Rohto Pharmaceut Co Ltd 安定化された組成物
US20040202677A1 (en) 2003-04-10 2004-10-14 Hopkins Kevin J. Method of enhanced regional body fat reduction
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
CN1593451A (zh) 2003-09-12 2005-03-16 杨喜鸿 促进男性勃起的外用药物
US7097859B2 (en) 2004-04-05 2006-08-29 Hack Jacob C Indium supplement compositions and methods therefor
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
US20060148837A1 (en) 2005-01-04 2006-07-06 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
MX2007009698A (es) * 2005-02-11 2007-09-26 Argenta Discovery Ltd Combinacion de compuestos de metilxantina y esteroides para tratar las enfermedades respiratorias cronicas.
GB2442828A (en) * 2005-02-11 2008-04-16 Argenta Discovery Ltd Combination of a methylxanthine compound and a steroid to treat chronic respiratory disease
GB2424185B (en) 2005-03-16 2009-12-30 Atulkumar Sumanbhai Patel A cough mixture
US20080003280A1 (en) 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
US20080085312A1 (en) 2006-10-04 2008-04-10 Auriga Laboratories, Inc. Multi-Phase Release Potassium Guaiacolsulfonate Compositions
US20080176955A1 (en) 2007-01-16 2008-07-24 Victory Pharma, Inc. Combined administration of benzonatate and guaifenesin
WO2009019598A2 (en) * 2007-08-03 2009-02-12 Dr. Reddy's Laboratories Ltd. Inhalation therapy for respiratory disorders
EP2207597B1 (en) * 2007-09-18 2020-02-19 La Jolla Institute for Allergy and Immunology Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment
DE102007000521A1 (de) 2007-10-18 2009-04-23 Renate Conrad Hustenpräparat
GB0921803D0 (en) 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
GB0919889D0 (en) 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
GB0921805D0 (en) 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
GB0919893D0 (en) 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
GB201014391D0 (en) 2010-08-27 2010-10-13 Biocopea Ltd Drug composition and its use in therapy
GB201111485D0 (en) 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US20120252824A1 (en) 2009-06-16 2012-10-04 John Brew Drug Combinations and Uses in Treating a Coughing Condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy

Also Published As

Publication number Publication date
WO2010146394A1 (en) 2010-12-23
ES2526560T3 (es) 2015-01-13
EP2442811B1 (en) 2014-11-19
JP5501451B2 (ja) 2014-05-21
US8703158B2 (en) 2014-04-22
EP2442811A1 (en) 2012-04-25
JP2012530121A (ja) 2012-11-29
GB0910375D0 (en) 2009-07-29
US20120128738A1 (en) 2012-05-24

Similar Documents

Publication Publication Date Title
ZA201202504B (en) Process for the preparation of calcobutrol
EP2414020A4 (en) GUIDING WIRE WITH FAVORABLE TIP
EP2391417A4 (en) GUIDEWIRE
GB0915515D0 (en) Treatment of vasculoproliferative conditions
IL214919A0 (en) Method for therapeutic use
IL213761A0 (en) Novel ortho-aminoamides for the treatment of cancer
IL217492A0 (en) Treatment method
IL206491A0 (en) Treatment of produce
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
GB0900599D0 (en) Treatment
PL2442811T3 (pl) Teobromina w terapii kaszlu
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
GB201013898D0 (en) Well treatment
GB0908101D0 (en) Treatment of stress
GB201001521D0 (en) Treatment
GB0913968D0 (en) Treatment
EP2499125A4 (en) PROCESS FOR DEDOLLING OMEPRAZOLE
EP2424539A4 (en) PROCESS FOR TREATING DEPRESSION
EP2440238A4 (en) Methods of Treatment
ZA201005770B (en) The treatment of damaged skin
PL389594A1 (pl) Sposób wytwarzania sulfidów fluorohalogenometyloarylowych
GB0905640D0 (en) Coffin
GB0904371D0 (en) Coffin
PL387172A1 (pl) Identyfikator trumny
GB201001517D0 (en) Treatment